Cleveland Clinic's Integrated Hospital Care Institute encompasses the departments of Pulmonary, Critical Care, Infectious Disease, Hospital Medicine, Emergency Medicine, and Anesthesia.

The Institute has realized enormous growth in the past several years, increasing the size of its faculty to over 750 physicians and expanding beyond the main campus to seven regional hospitals and 10 free-standing outpatient facilities.

Our physicians possess wide-ranging clinical expertise and oversee a number of nationally renowned referral programs serving both common (sarcoidosis, cystic fibrosis, pulmonary vascular disease, lung cancer, interstitial lung disease, asthma, neuromuscular disease) and uncommon (lymphangioleiomyomatosis, hereditary hemorrhagic telangiectasia) disease populations.

Our lung transplant program is consistently ranked among the top 3 centers for lung transplant volume and specializes in high-risk transplant patients who are frequently turned down by other centers.

Members of our Interventional Pulmonology section perform over 3500 bronchoscopies annually and offer state of the art diagnostic and therapeutic options for patients.

Our medical ICU is among the largest in the United States with 65 beds. Teams care for patients in a specialized format with 6 rounding services, a dedicated procedure team and dedicated Liver and ECMO teams.

As a testament to our clinical strengths, Cleveland Clinic is ranked as one of the nation's top hospitals by U.S. News & World Report.

Coupled with our clinical initiatives is a thriving research enterprise that encompasses virtually all areas of Pulmonary and Critical Care medicine. Several faculty hold joint appointments in the Lerner Research Institute where they run NIH-funded basic science labs investigating molecular and cellular mechanisms relevant to pulmonary fibrosis, pulmonary hypertension and asthma. Numerous other members of the Integrated Hospital Care Institute (IHI) have participated and continue to lead major NIH-sponsored collaborative clinical trials networks including Idiopathic Pulmonary Fibrosis Clinical Research Network, Prevention and Early Treatment of Acute Lung Injury (PETAL), Long Term Oxygen Treatment Trial (LOTT) for COPD and the Clinical Trials in Organ Transplantation.